CD36 and urinary bladder cancer: Similarly, circZNF609 stabilizes the IGF2BP2/CD36 complex in bladder cancer to promote fatty acid uptake, thereby activating PPAR signaling and supporting lipid-dependent tumor growth while impairing T-cell metabolic fitness and reducing immunotherapy responsiveness (40).